Arcutis Biotherapeutics, Inc. ($ARQT)
Filing Information
| Accession Number | 0001628280-26-014325 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 3, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
99,853
Total Value
$71,843.94
P&L
+inf% (+$2,154,370.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SVP Chief Financial Officer | Common Stock | โ | Feb 27, 2026 | Grant/Award | 27,000 | $0.00 | $0.00 | 90,607 | Direct | โ | View Details | |
SVP Chief Financial Officer | Common Stock | โ | Mar 2, 2026 | Sale | 2,772 | $25.16 | $69,744.91 | 87,835 | Direct | โ | View Details | |
SVP Chief Financial Officer | Common Stock | โ | Mar 2, 2026 | Sale | 81 | $25.91 | $2,099.03 | 87,754 | Direct | โ | View Details | |
SVP Chief Financial Officer | Stock Option (right to buy) | Derivative | Feb 27, 2026 | Grant/Award | 70,000 | $0.00 | $0.00 | 70,000 | Direct | โ | View Details |